Related Experiment Video
Updated: May 23, 2026
03:10
Microscopic Cyst Resection for the Treatment of Patients Diagnosed with Epididymal Cyst
Published on: March 31, 2023
[Ruptured pulmonary hydatid cyst: a case report]
Tanju Çelik1, Bülent Akçora, Murat Tutanç
1Mustafa Kemal Üniversitesi, Tayfur Ata Sökmen Tıp Fakültesi, Pediatri Anabilim Dalı, Hatay, Türkiye, Turkey. dr.tanju35@hotmail.com
Turkiye Parazitolojii Dergisi
|March 28, 2012
Summary
Hydatid cyst (HD) is a parasitic disease transmitted by dogs, commonly affecting the lungs and liver. This case report details a child diagnosed with lung HD presenting with respiratory symptoms.
Area of Science:
- Parasitology
- Infectious Diseases
- Pediatric Medicine
Background:
- Hydatid cyst (HD) is a global zoonotic disease caused by Echinococcus granulosus.
- Transmission to humans typically occurs via ingestion of contaminated food or water, often linked to canine feces.
- Prevalence is high in agricultural regions with significant animal husbandry.
Observation:
- Echinococcus granulosus larvae can establish cysts in various organs, most commonly the liver and lungs.
- Pulmonary hydatid disease (HD) may manifest with nonspecific symptoms like cough, chest pain, dyspnea, fever, and hemoptysis.
- Diagnostic tools include imaging such as chest X-ray and tomography, alongside physical examination.
Findings:
- Surgical intervention, including cystectomy and capitonnage, is the primary treatment for lung hydatid disease (HD).
- Medical management with albendazole is reserved for complex cases, such as unresectable lesions or patients unsuitable for surgery.
- This report highlights a pediatric case of lung hydatid disease (HD) presenting with significant respiratory and systemic symptoms.
Implications:
- Early diagnosis and appropriate management of lung hydatid disease (HD) are crucial for favorable patient outcomes.
- Understanding the transmission routes and clinical presentations aids in preventing and controlling Echinococcus granulosus infections.
- This case underscores the importance of considering parasitic infections in pediatric patients with persistent respiratory symptoms.
Related Concept Videos
01:26Pneumothorax-I
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
01:28Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:28Esophageal Perforation-II: Clinical Manifestations and Management
Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
Clinical Manifestations:
01:08Pneumothorax II: Pathophysiology
Pneumothorax means the presence of air in the pleural space — the thin potential gap between the visceral and parietal pleura. This condition disrupts the normal pressure balance that keeps the lungs inflated, leading to partial or complete collapse of the affected lung.Normal physiologyUnder normal conditions, the pleural space maintains a slightly negative intrapleural pressure, which keeps the lungs expanded against the chest wall. This negative pressure creates a delicate balance between...
01:27Pneumothorax-II
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
01:29Pulmonary Embolism I: Introduction
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...